The global molecular methods market for food safety testing size was valued at USD 1.7 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2019 to 2026. With the globalization of food production and distribution, associated hazards such as a rise in numbers of food recalls and frequent cases of foodborne illness have become common. To effectively address these challenges, molecular methods for food safety testing have been witnessing significant research investments.
Government organizations are playing a major role in driving the market by improving their surveillance and detection methods for monitoring the supply chain. For instance, in July 2019, the European Food Safety Authority (EFSA) introduced a new set of priorities focusing on innovation in risk assessment, holistic risk assessment, and improve food safety with the implementation of alternative and sustainable production systems.
Investments in the development of automated molecular methods to overcome associated challenges such as time and resource consumption have significantly driven market revenue. For instance, in July 2019, 3M partnered with Hamilton to combine its molecular detection system with Hamilton’s food insect NIMBUS to offer an automated workflow for pathogen testing.
Key producers like Tyson Foods are undertaking efforts to assure supply chain transparency and provide composition intricacies to allow their customers to make informed decisions for purchase. This has driven the development of novel technologies such as the introduction of blockchain technology, an electronic bookkeeping system, to effectively trace shipment details.
Moreover, acceptance of third-party service providers offering a wide range of molecular testing services is playing a vital role in spurring revenue growth. Reformation of the regulatory structure for food testing and labeling labs has also augmented the growth of the service-based business model of the market.
Polymerase Chain Reaction (PCR) accounted for the largest revenue share in 2018. This molecular method provides high sensitivity and specificity for pathogen detection and reduces the overall process turnaround time. Besides, there have been constant improvements in PCR platforms, such as the effective implementation of real-time (RT) PCR for point-of-care applications in pathogen detection, which drives segment growth.
Owing to the various advantages associated with the use of PCR technology, in November 2018, Bio-Rad received the contract for its automated iQ-Check RT-PCR testing kits and sample preparation system from the U.S. Department of Agriculture (USDA). Currently, automated PCR methods are recognized as one of the fastest developing analytical methods for the detection of microbial toxins and foodborne pathogens.
Rapid advancements in electrochemical biosensors have significantly improved the quantitative detection of contaminants. Biosensor technology effectively addresses the limitations of conventional analytical methods by providing high precision analytical specificity within complex food matrices.
The emergence of molecular methods that involve the use of state-of-the-art assay techniques and ready-to-use reagents for safety testing has significantly addressed various challenges associated with the conventional model of a food safety screening. The molecular methods market for food safety testing has been segmented based on product into instruments, reagents, and consumables, and services.
The reagents and consumables segment dominated the global market with a revenue share of over 50.0% in 2018 and is expected to maintain its dominance throughout the forecast period. The availability of a wide range of reagents and kits, coupled with a high utilization and purchasing rate of these products for pathogen detection, contributed to the dominant share of this segment.
Ongoing technological advancements, such as integration of automated solutions into manual molecular testing techniques, offer significant potential for accurate and fast pathogen testing. Increasing the application of lab-on-a-chip or microarray technology for pathogen detection boosts the instrument segment. This segment is expected to exhibit the fastest growth throughout the forecast period.
North America accounted for the largest share in the market for molecular methods or food safety testing in 2018. Presence of several food safety regulations in the U.S., such as the Food Safety Modernization Act, the Food, Drug, and Cosmetic Act, the Poultry Products Inspection Act, and the Federal Meat Inspection Act of 1906, stipulates testing of food products and processes at every stage. The employment of these safety protocols drives the regional market.
Asia Pacific is expected to witness the fastest growth rate soon. This is attributive to efforts undertaken by government entities to improve the technical competence of food safety management throughout the region. For instance, in March 2019, the Chinese government unveiled a new set of food safety guidelines for the local government.
Companies have been adopting several strategic initiatives to reinforce their market presence and maintain a competitive share. These strategies include novel product development, collaborative and partnership models, and geographic expansion strategies in untapped regions.
For instance, in March 2019, 3M introduced a new Molecular Detection Assay 2 along with new 3M Campylobacter enrichment broth for efficient testing of Campylobacter linked with poultry production. This new system is designed to enable testing with easier workflow with accuracy for product analysis in the poultry industry. Some of the prominent players in molecular methods market for food safety testing include:
QIAGEN
3M
Veredus Laboratories
NEOGEN CORPORATION
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
bioMérieux SA
ArcherDX, Inc.
HiMedia Laboratories
Eurofins Scientific
SGS SA
Report Attribute |
Details |
The market size value in 2020 |
USD 2.0 billion |
The revenue forecast in 2026 |
USD 2.9 billion |
Growth Rate |
CAGR of 6.8% from 2019 to 2026 |
The base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Technology, product, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; China; Japan; Brazil; South Africa |
Key companies profiled |
QIAGEN; 3M; Veredus Laboratories; NEOGEN CORPORATION; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; bioMérieux SA; ArcherDX, Inc.; HiMedia Laboratories; Eurofins Scientific; SGS SA |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global molecular methods market for food safety testing report based on technology, product, and region:
Technology Outlook (Revenue, USD Million, 2015 - 2026)
Polymerase Chain Reaction (PCR)
Immunoassay
Biosensors
Microarray
Others
Product Outlook (Revenue, USD Million, 2015 - 2026)
Instrument
Reagents & Consumables
Services
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
Japan
Latin America
Brazil
Middle East and Africa (MEA)
South Africa
b. The global molecular methods market for food safety testing size was estimated at USD 1.8 billion in 2019 and is expected to reach USD 2.0 billion in 2020.
b. The global molecular methods market for food safety testing is expected to grow at a compound annual growth rate of 6.5% from 2020 to 2026 to reach USD 2.9 billion by 2026.
b. Polymerase Chain Reaction (PCR) dominated the molecular methods market for food safety testing with a share of 39.8% in 2019. This molecular method provides high sensitivity and specificity for pathogen detection and reduces the overall process turnaround time.
b. Some key players operating in the molecular methods market for food safety testing include QIAGEN; 3M; Veredus Laboratories; NEOGEN CORPORATION; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; bioMérieux SA; ArcherDX, Inc.; HiMedia Laboratories; Eurofins Scientific; and SGS SA.
b. Key factors that are driving the market growth include improvement in food safety regulations, the introduction of automation in food testing protocols, a growing burden of foodborne illness, and a rise in demand for packaged and organic food products.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.